Isolation and screening of lactic acid bacteria
The resulting isolated LAB colonies were labeled as CS-1, CS-2, CS-3 and so on. Out of 52, 11 isolates (CS1-CS11) were selected and Gram stained. All isolates were observed to be non-motile and lacked endospore formation growth is recorded at 37°C in MRS medium (Table 1). Eleven purified colonies, exhibiting Gram-positive, bacilli and negative catalase activity, were subjected to further identification through microscopic and biochemical analyses in Table 2 and Fig 1.
Carbohydrate fermentation
The sugar fermentation profiles of different LAB isolates were evaluated by using different sugars. The strains ferment sugars, however, variations in sugar utilization were observed among the selected organisms, indicating the unique characteristics of each isolate (Table 2).
Preliminary identification of Lactic acid bacterial species
Selected isolate is identified by VITEK 2 Compact system (biome Rieux®). The technique used here is advanced colorimetric, the microbes are identified by biochemical tests. VITEK 2 system database results help in the identifications and classification of microorganisms.
Monitoring growth at different temperatures
The growth at different temperatures such as 10, 21, 37 and 42°C were assessed for selected LAB isolates. Growth at 10°C was observed in 25.78% of the isolates, whereas 44.3% exhibited growth at 37°C. Values were represented in means of three replicates; dissimilar letters show significant difference (p<0.05). Most isolates, including CS-2, CS-3, CS-7, CS-8 and CS-11, shows peak growth at Optimal temperature 37°C, suggesting they are well-adapted to human body temperature. All the isolates showed no growth at 10°C, Growth rate decreases at higher temperature of 42°C, though isolates like CS-8 and CS-9 shows moderate growth, suggesting some adaptability to slightly elevated temperatures (Fig 2).
Hemolytic activity
The hemolysis test revealed that most isolates (CS-1, CS-2, CS-3 and CS-11) were non-hemolytic, indicating safety for probiotic use. A few isolates (CS-4, CS-6, CS-7) showed β-hemolysis, suggesting pathogenic potential (Table 3).
Confirmation of isolated strain as LAB by 16S rRNA
The molecular identification is confirmed by 16S rRNA sequencing. It was commercially sequenced at Institute of Barcode Biosciences Pvt. Ltd at Bangalore. Phylogenetic analysis was performed. CS-2 sample was found to be
Lactococcus lactis showed close similarity based on sequence homology and phylogenetic evaluation (Fig 3). The obtained 16S rRNA sequence was deposited in GenBank and provided with an accession number, PV125035.
Selection of potential species of LAB by various tests
Determination of optimal growth at different pH
All LAB isolates were exposed to acidic conditions at pH level from 1 to 4 and incubated at 37°C for 24 hours. Isolates CS-2, CS-3, CS-5, CS-6, CS-7 and CS-11 exhibited survival under these conditions. Among them, CS-2, CS-3, CS-5 and CS-7 demonstrated higher tolerance by surviving up to 3 hours in highly acidic environments. The remaining isolates showed decreased survival, failing to tolerate the low pH for longer than 90 minutes (Fig 4).
Tolerance to bile salt
The strains showed good survival and growth across bile salt concentrations of 0.05-2.5%, indicating their tolerance to bile conditions. The survival rates under bile salt at concentration of >0.3% w/v for 11 isolated strains were tested. From the graph (Fig 5), isolates CS-2, CS-5, CS-6 and CS-7 show relatively high tolerance growth than others. This potentiality shows the potentiality of probiotic strains with the ability to persist and remain viable within the GIT.
Tolerance to NaCl
NaCl tolerance test of the 11 isolates showed that they were able to grown in different concentration ranges between 1 to 6%. Among these, strains CS-2 and CS-3 exhibited growth comparatively with other isolates (Fig 6).
Antibiotic susceptibility test
The LAB isolates CS-2, CS-3 and CS-5 were tested for antibiotic susceptibility using antibiotics like; amikacin, ciprofloxacin, clindamycin, erythromycin, ceftriaxone, amoxicillin, tetracycline, gentamycin and vancomycin. The isolate CS-2 exhibited the maximum level of sensitivity, with inhibition zones of diameter of 22 mm against amoxicillin and 21 mm against clindamycin. Isolate CS-3 showed an inhibition zone of 20 mm against ceftriaxone, while CS-5 isolate exhibited an zone inhibition of 20 mm against vancomycin. The results are tabulated in Table 4 and Fig 7.
Antimicrobial activity
Selected LAB’s antimicrobial activity is examined for isolates by using modified agar well diffusion method. Pathogens such as
E. coli,
Pseudomonas aeruginosa and
S. aureus and
C. albican’s are used for the test of antagonistic effects of LAB. From the isolated 11 LAB, the 3 LAB are selected for the antagonistic activity. The level of antagonistic activity differed among the LAB strains; however, the selected isolates exhibited inhibitory effects against all the tested indicator microorganisms (Table 5). The CS-2 isolate exhibited the highest level of antimicrobial activity (Fig 8).
Test for minimum inhibitory concentration (MIC)
The overall MIC result is concluded as, that all three samples (CS-2, CS-3 and CS-6) exhibit concentration-dependent antimicrobial activity against both Gram-positive and Gram-negative bacteria. Among them, the highest inhibitory effect is shown by CS-2, particularly against
Pseudomonas aeruginosa and
Escherichia coli, achieving complete inhibition at lower concentrations. CS-3 displayed superior activity against
Enterococcus faecalis, while CS-6 showed comparatively lower efficacy.
Staphylococcus aureus appeared more resistant than other organisms. These findings suggest that the tested samples possess significant broad-spectrum antimicrobial properties, with CS-2 being the most potent isolate (Fig 9).
The present study, selective MRS agar proved for the isolation and functional attributes of LAB from commercially available probiotic supplements, as it facilitated efficient LAB isolation by promoting their growth while suppressing competing microbiota. This observation is considered with earlier findings
Yadav et al. (2024) confirming the suitability of MRS for LAB growth.
A Considerable variation in LAB diversity and viable counts was observed among the analyzed supplements, highlighting the lack of uniform standardization in commercial probiotic formulations and also reported by
Hill et al. (2014). Such differences in strain composition and population density are significant, as probiotic efficacy is both strain-specific and dose-dependent (
FAO/WHO, 2002;
Sanders et al., 2019).
Phenotypic, biochemical and 16S rRNA gene sequencing revealed a diverse LAB community, including
Lactococcus, Lactobacillus, Pediococcus, Leuconostoc and
Bifidobacterium. The findings are similar with previous studies on commercial probiotics
(Ouwehand et al., 2002). Additionally, the consideration of species of
Enterococcus and
Streptococcus indicates the expanding diversity of probiotic strains. However, their use warrants careful safety evaluation due to potential opportunistic pathogenicity
(Hill et al., 2014; Sanders et al., 2019).
Functional characterization showed that most isolates tolerated acidic conditions (pH 2.0-4.0) and bile salts, indicating their ability to survive gastrointestinal transit, this observation aligns with probiotic selection criteria (
FAO/WHO, 2002). Several isolates exhibited antibacterial and antifungal activity against common pathogens, due to the production of organic acids, hydrogen peroxide and bacteriocins similar observations are considered by
Havenaar and Huis (1992);
Ouwehand et al. (2002).
Notably, strains CS-2 and CS-3 demonstrated strong, strain-specific antimicrobial efficacy, underscoring the functional diversity of probiotic LAB. The findings further highlight the importance of strain evaluation for probiotic efficacy
(Sanders et al., 2019).